
Current Protocols in Immunology
Last Update: April 11, 2013
Print ISSN: 1934-3671
Online ISSN: 1934-368X
- Overview
- Table of Contents
- New Protocols
- Sample Unit
- Editors & Contributors
Table of Contents
-
Chapter 1 Care and Handling of Laboratory Animals
-
Section I Animal Health and Husbandry
-
Section II Use of Mouse, Rat, Hamster, and Rabbit
-
Section III Selected Surgical Procedures
-
-
Chapter 2 Induction of Immune Responses
-
Section I Assays for Antibody Production
-
Section II Production of Antibodies
-
Section III Purification and Fragmentation of Antibodies
-
Section IV Specialized Techniques
- Unit 2.11 Preparation of Immune Stimulating Complexes (ISCOMs) as Adjuvants
- Unit 2.12 Cloning, Expression, and Modification of Antibody V Regions
- Unit 2.13 Production of Bispecific Antibodies
- Unit 2.14 Nucleic Acid Immunizations
- Unit 2.15 Vaccination of Mice with Baculovirus‐Infected Insect Cells Expressing Antigenic Proteins
- Unit 2.16 Efficient Delivery of Antibody Into Living Cells Using Hemagglutinating Virus of Japan (HVJ) Envelope
-
-
Chapter 3 In Vitro Assays for Mouse Lymphocyte Function
-
Section I Isolation and Fractionation of Mononuclear Cell Populations
- Unit 3.1 Isolation of Mouse Mononuclear Cells
- Unit 3.2 T Cell Enrichment By Nonadherence to Nylon
- Unit 3.3 T Cell Enrichment by Cytotoxic Elimination of B Cells and Accessory Cells
- Unit 3.4 T Cell Depletion by Cytotoxic Elimination
- Unit 3.5A Fractionation of T and B Cells Using Magnetic Beads
- Unit 3.5B Isolation of Ly‐1+/CD5+ B Cells by Cell Sorting
- Unit 3.6 Depletion of Accessory Cells by Adherence to Sephadex G‐10
- Unit 3.7 Isolation of Dendritic Cells
-
Section II Assays for B Cell Function
-
Section III Assays for T Cell Function
- Unit 3.11 Induction and Measurement of Cytotoxic T Lymphocyte Activity
- Unit 3.12 Proliferative Assays for T Cell Function
- Unit 3.13 Production of TH1 and TH2 Cell Lines and Clones
- Unit 3.14 Production of Mouse T Cell Hybridomas
- Unit 3.15 Quantitation of Functional T Cells by Limiting Dilution
- Unit 3.16 Granule Enzyme Exocytosis Assay for Cytotoxic T Lymphocyte Activation
-
Section IV Related Isolation Procedures and Functional Assays
- Unit 3.17 Measurement of Apoptosis and Other Forms of Cell Death
- Unit 3.18 In Vitro Systems for the Study of T Cell Development: Fetal Thymus Organ Culture and OP9‐DL1 Cell Coculture
- Unit 3.19 Isolation of Mouse Lymphocytes from Small Intestine Tissues
- Unit 3.20 Isolation of Mouse Neutrophils
- Unit 3.21 Isolation of Mouse Intrahepatic Lymphocytes
- Unit 3.22 Isolation of Murine Natural Killer Cells
- Unit 3.23 Generation, Isolation, and Maintenance of Rodent Mast Cells and Mast Cell Lines
- Unit 3.24 Generation and Characterization of Mouse Basophils from Bone Marrow and Purification of Basophils from Spleen
-
-
Chapter 4 In Vivo Assays for Lymphocyte Function
- Introduction
- Unit 4.1 In Vivo Depletion of CD4‐ and CD8‐Specific T Cells
- Unit 4.2 Contact Hypersensitivity
- Unit 4.3 Animal Models of Acute and Chronic Graft‐Versus‐Host Disease
- Unit 4.4 Skin Allograft Rejection
- Unit 4.5 Delayed‐Type Hypersensitivity
- Unit 4.6 Assessment of Lymphocyte Development in Radiation Bone Marrow Chimeras
- Unit 4.7 Measurement of T and B Cell Turnover with Bromodeoxyuridine
- Unit 4.8 Construction of Human‐SCID Chimeric Mice
- Unit 4.9 Use of the Intracellular Fluorescent Dye CFSE to Monitor Lymphocyte Migration and Proliferation
-
Chapter 5 Immunofluorescence and Cell Sorting
- Introduction
- Unit 5.1 Overview of Flow Cytometry
- Unit 5.2 Analysis of Flow Cytometry Data
- Unit 5.3 Preparation of Cells and Reagents for Flow Cytometry
- Unit 5.4 Flow Cytometry Analysis Using the Becton Dickinson FACS Calibur
- Unit 5.5 Measurement of Intracellular Ions by Flow Cytometry
- Unit 5.6 Measurement of Intercellular Conjugates by Flow Cytometry
- Unit 5.7 Analysis of Cellular DNA Content by Flow Cytometry
- Unit 5.8 Multiparameter FACS Analysis
- Unit 5.9 Visualization of Multiprotein Complexes by Flow Cytometry
-
Chapter 6 Cytokines and Their Cellular Receptors
- Introduction
- Unit 6.1 Measurement of Lymphokine Receptors
- Unit 6.2 Measurement of Soluble and Membrane‐Bound Interleukin 1 Using a Fibroblast Bioassay
- Unit 6.3 Measurement of Human and Murine Interleukin 2 and Interleukin 4
- Unit 6.4 Measurement of Interleukin 3 and Other Hematopoietic Cytokines, such as GM‐CSF, G‐CSF, M‐CSF, Erythropoietin, Steel Factor, and Flt‐3 Ligand
- Unit 6.5 Measurement of Mouse and Human Interleukin 5
- Unit 6.6 Measurement of Interleukin 6
- Unit 6.7 Measurement of Interleukin 7
- Unit 6.8 Measurement of Mouse and Human Interferon γ
- Unit 6.9 Measurement of Antiviral Activity Induced by Interferons α, β, and γ
- Unit 6.10 Measurement of Tumor Necrosis Factor α and β
- Unit 6.11 Measurement of TGF‐β in Biological Fluids
- Unit 6.12 Biological Responses to Chemokine Superfamily Members
- Unit 6.13 Measurement of Mouse and Human Interleukin 9
- Unit 6.14 Measurement of Mouse and Human Interleukin 10
- Unit 6.15 Measurement of Human Interleukin 11
- Unit 6.16 Measurement of Human and Mouse Interleukin‐12
- Unit 6.17 Measurement of Human and Murine Stem Cell Factor (c‐kit Ligand)
- Unit 6.18 Measurement of Interleukin‐13
- Unit 6.19 ELISPOT Assay to Detect Cytokine‐Secreting Murine and Human Cells
- Unit 6.20 Immunoenzymetric Assay of Mouse and Human Cytokines Using NIP‐Labeled Anti‐Cytokine Antibodies
- Unit 6.21 Detection of Cytokine Receptors by Flow Cytometry
- Unit 6.22 Measurement of Interleukin 15
- Unit 6.23 Measurement of Interleukin 16
- Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry
- Unit 6.25 Measurement of Interleukin‐17
- Unit 6.26 Measurement of Human and Mouse Interleukin 18
- Unit 6.27 Detection and Isolation of Cytokine Secreting Cells Using the Cytometric Cytokine Secretion Assay
- Unit 6.28 The In Vivo Cytokine Capture Assay for Measurement of Cytokine Production in the Mouse
- Unit 6.29 Cytokine, Growth Factor, and Chemokine Ligand Database
- Unit 6.30 Measurement of Interleukin‐21
-
Chapter 7 Immunologic Studies in Humans
-
Section I Preparation of Human Mononuclear Cell Populations and Subpopulations
- Unit 7.1 Isolation of Whole Mononuclear Cells from Peripheral Blood and Cord Blood
- Unit 7.2 Isolation of T Cells Using Rosetting Procedures
- Unit 7.3 Purification of T Cell Subpopulations
- Unit 7.4 Immunomagnetic Purification of T Cell Subpopulations
- Unit 7.4B The Purification and Functional Analysis of Human CD4+CD25high Regulatory T Cells
- Unit 7.5 Isolation of Human B Cell Populations
- Unit 7.6A Isolation of Human Monocyte Populations
- Unit 7.6B Isolation and Purification of Human Intestinal Macrophages
- Unit 7.7 Isolation of Human NK Cells and Generation of LAK Activity
- Unit 7.8 Isolation of Mononuclear Cells from Tonsillar Tissue
- Unit 7.9 Detection of Unseparated Human Lymphocytes by Flow Cytometry
-
Section II Measurement of Basic Immunologic Characteristics of Human Mononuclear Cells
- Unit 7.10 Measurement of Proliferative Responses of Cultured Lymphocytes
- Unit 7.11 Induction of Polyclonal Immunoglobulin Synthesis
- Unit 7.12 Measurement of Polyclonal Immunoglobulin Synthesis Using ELISA
- Unit 7.13 Measurement of Polyclonal Immunoglobulin Synthesis Using the Reverse Plaque Technique
- Unit 7.14 Measurement of Immunoglobulin Synthesis Using the ELISPOT Assay
- Unit 7.15 Measurement of In Vitro Specific‐Antibody Synthesis
- Unit 7.16 Induction and Measurement of In Vivo Antibody Responses
- Unit 7.17 Measurement of Polyclonal and Antigen‐Specific Cytotoxic T Cell Function
- Unit 7.18 Measurement of Cytotoxic Activity of NK/LAK Cells
- Unit 7.18B Measurement of Cytokine Production Using Whole Blood
-
Section III Long‐Term and Immortalized Human Cell Lines and Clones
- Unit 7.19 Generation and Maintenance of Cloned Human T Cell Lines
- Unit 7.20 Generation of HTLV‐I‐Transformed T Cell Lines
- Unit 7.21 Herpesvirus saimiri Transformation of Human T Lymphocytes
- Unit 7.21B Immortalization of Human and Rhesus Macaque Primary Antigen‐Specific T Cells by Retrovirally Transduced Telomerase Reverse Transcriptase
- Unit 7.22 Generation of Epstein‐Barr Virus (EBV)–Immortalized B Cell Lines
-
Section IV Preparation and Functional Analysis of Other Human Lymphoid and Nonlymphoid Cells
- Unit 7.23 Isolation and Functional Analysis of Neutrophils
- Unit 7.24 Isolation of Human Basophils
- Unit 7.25 Isolation of Tissue Mast Cells
- Unit 7.26 Measuring Degranulation of Mast Cells
- Unit 7.27 51Cr Release Assay of Antibody‐Dependent Cell‐Mediated Cytotoxicity (ADCC)
- Unit 7.28 Measurement of Cellular Adhesion Under Static Conditions
- Unit 7.29 Cell Adhesion Under Hydrodynamic Flow Conditions
- Unit 7.30 Isolation of Human Intestinal Mucosal Mononuclear Cells
- Unit 7.31 Isolation of Human Eosinophils
- Unit 7.32 Isolation and Generation of Human Dendritic Cells
- Unit 7.33 Measurement of Prostaglandins and Other Eicosanoids
- Unit 7.34 Isolation and Characterization of Human Natural Killer Cell Subsets
- Unit 7.35 Assays for B Cell and Germinal Center Development
- Unit 7.36 In Vitro Models of Human T Cell Anergy
- Unit 7.37 Generation, Isolation, and Maintenance of Human Mast Cells and Mast Cell Lines Derived from Peripheral Blood or Cord Blood
- Unit 7.38 Measuring Mast Cell Mediator Release
- Unit 7.39 Evaluation of Human Natural Killer Cell Activities in Whole Blood
- Unit 7.40 Isolation of Cells from the Feto‐Maternal Interface
-
-
Chapter 8 Isolation and Analysis of Proteins
-
Section I Solubilization of Cellular Proteins
-
Section II Isolation of Proteins Using Antibodies
-
Section III Electrophoretic Separation of Proteins
-
Section IV Detection of Proteins
- Unit 8.9 Staining Proteins in Gels
- Unit 8.10 Immunoblotting and Immunodetection
- Unit 8.11 Iodination of Soluble and Membrane‐Bound Proteins
- Unit 8.12 Biosynthetic Labeling of Proteins
- Unit 8.13 Metabolic Radiolabeling of Animal Cell Glycoconjugates
- Unit 8.14 Inhibition of N‐Linked Glycosylation
- Unit 8.15 Endoglycosidase and Glycoamidase Release of N‐Linked Glycans
- Unit 8.16 Biotinylation and Analysis of Membrane‐Bound and Soluble Proteins
- Unit 8.17 Single‐Cell Phospho‐Protein Analysis by Flow Cytometry
-
-
Chapter 9 Peptides
- Introduction
- Unit 9.1 Introduction to Peptide Synthesis
- Unit 9.2 Synthetic Peptides for Production of Antibodies that Recognize Intact Proteins
- Unit 9.3 Production of Anti‐Peptide Antisera
- Unit 9.4 B Cell Epitope Mapping Using Synthetic Peptides
- Unit 9.5 Identification of B Cell and T Cell Epitopes Using Synthetic Peptide Combinatorial Libraries
- Unit 9.6 Synthesis and Application of Peptide Dendrimers As Protein Mimetics
- Unit 9.8 Phage Display Selection, Analysis, and Prediction of B Cell Epitopes
- Unit 9.9 Epitope Mapping Using Gram‐Positive Surface Display
-
Chapter 10 Molecular Biology
-
Section I Isolation and Purification of DNA
-
Section II Resolution and Recovery of DNA Fragments
-
Section III Analysis of Genomic DNA by Blotting and Hybridization
-
Section IV Enzymatic Cleavage and Labeling of DNA
-
Section V Preparation and Analysis of RNA
-
Section VI Transfection and Expression of Cloned DNA
- Unit 10.13 Calcium Phosphate Transfection
- Unit 10.14 Transfection Using DEAE‐Dextran
- Unit 10.15 Transfection by Electroporation
- Unit 10.16 Liposome‐Mediated Transfection
- Unit 10.17A Stable Transfer of Genes into Mammalian Cells
- Unit 10.17B Transfection of Lymphoid Cells
- Unit 10.17C Rapid Production of Retroviruses for Efficient Gene Delivery to Mammalian Cells Using 293T Cell–Based Systems
- Unit 10.17D Use of the Hemagglutinating Virus of Japan (HVJ) Envelope as a Versatile Delivery System for Nucleic Acids and Proteins to Leukocytes In Vitro
- Unit 10.17E Efficient In Vivo Delivery of Plasmids and Oligonucleotides Using Hemagglutinating Virus of Japan Envelope (HVJ‐E) Vector in Immunological Disease Models
- Unit 10.18 Use of Monoclonal Antibodies for Expression Cloning
- Unit 10.19A Construction of Immunoglobulin Fusion Proteins
- Unit 10.19B Phage Display of Single‐Chain Antibody Constructs
-
Section VII The Polymerase Chain Reaction
- Unit 10.20 Enzymatic Amplification of DNA by PCR: Standard Procedures and Optimization
- Unit 10.21 Quantitation of Rare DNAs by PCR
- Unit 10.22 Detection of Isotype Switch Rearrangement in Bulk Culture by PCR
- Unit 10.23 Detection of Cytokine mRNA Expression by PCR
- Unit 10.24 cDNA Amplification Using One‐Sided (Anchored) PCR
- Unit 10.25 Double‐Stranded DNA Sequence Analysis
- Unit 10.26 Evaluating Human T Cell Receptor Gene Expression by PCR
- Unit 10.27 Molecular Analysis of Mouse T Cell Receptor Expression Using PCR
- Unit 10.28 Spectratype/Immunoscope Analysis of the Expressed TCR Repertoire
- Unit 10.29 Multiprobe Ribonuclease Protection Assay for Simultaneous Measurement of mRNA Expression
- Unit 10.30 Analysis of Telomere Length and Telomerase Activity
- Unit 10.31 Measurement of Mouse T Cell Receptor Excision Circles
- Unit 10.32 Use of Bacterial Artificial Chromosomes in Generating Targeted Mutations in Human and Mouse Cytomegaloviruses
- Unit 10.33 Unbiased Molecular Analysis of T Cell Receptor Expression Using Template‐Switch Anchored RT‐PCR
-
-
Chapter 11 Biochemistry of Cell Activation
- Introduction
- Unit 11.1 Phosphoinositide and Inositol Phosphate Analysis in Lymphocyte Activation
- Unit 11.2 Preparation and Analysis of Phosphorylated Proteins
- Unit 11.3 Detecting Tyrosine‐Phosphorylated Proteins by Western Blot Analysis
- Unit 11.4 Immune‐Complex Assays for Tyrosine Protein Kinases
- Unit 11.5 Assessment of the Effects of Tyrosine Protein Kinase Inhibitors
- Unit 11.6 Production of Antibodies that Recognize Specific Tyrosine‐Phosphorylated Peptides
- Unit 11.7 Protein Tyrosine Phosphatase Assays
- Unit 11.8 Analyzing Mitogen‐Activated Protein Kinase (MAPK) Activities in T Cells
- Unit 11.9A Key Molecules Involved in Receptor‐Mediated Lymphocyte Activation
- Unit 11.9B Signal Transduction During Activation and Inhibition of Natural Killer Cells
- Unit 11.9C Apoptosis Signaling Pathways
- Unit 11.9D TRAF‐Mediated TNFR‐Family Signaling
- Unit 11.10 Isolation and Use of Rafts
-
Chapter 12 Detection and Analysis of HIV
- Introduction
- Unit 12.1 General Guidelines for Experimenting with HIV
- Unit 12.2 Isolation and Quantitation of HIV in Peripheral Blood
- Unit 12.3 Infection of CD4+ Primary T Cells and Cell Lines, Generation of Chronically Infected Cell Lines, and Induction of HIV Expression
- Unit 12.4 Culture of HIV in Monocytes and Macrophages
- Unit 12.5 Detection Assays for HIV Proteins
- Unit 12.6 Detection of HIV DNA and RNA Using PCR
- Unit 12.7 Regulation of the HIV Promoter/Enhancer
- Unit 12.8 In Situ Hybridization for Detection of HIV RNA
- Unit 12.9 In Vitro Evaluation of Experimental Agents for Anti‐HIV Activity
- Unit 12.10 Vaccinia‐Based Reporter Gene Cell‐Fusion Assays to Quantitate Functional Interactions of HIV Envelope Glycoprotein with Receptors
- Unit 12.11 Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
- Unit 12.12 Immunophenotyping of T Cell Subpopulations in HIV Disease
- Unit 12.13 Evaluation of B Cell Function in Patients with HIV
-
Chapter 13 Complement
- Introduction
- Unit 13.1 Classical Pathway Evaluation
- Unit 13.2 Alternative Pathway Evaluation
- Unit 13.3 Isolation and Purification of C3 from Human Plasma
- Unit 13.4 Assays for Membrane Complement Receptors
- Unit 13.5 Isolation and Functional Assay of the Membrane Complement Inhibitors CD55 (DAF) and CD59 (MIRL)
- Unit 13.6 Assays for the Mannan‐Binding Lectin Pathway
- Unit 13.7 Assays for Complement Proteins Encoded in the Class III Region of Human MHC
- Unit 13.8 Human Complement Components C4A and C4B Genetic Diversities: Complex Genotypes and Phenotypes
-
Chapter 14 Innate Immunity
- Introduction
- Unit 14.1 The Isolation and Characterization of Murine Macrophages
- Unit 14.2 Activation of Murine Macrophages
- Unit 14.3 Characterization of Human Monocytes/Macrophages
- Unit 14.5 Oxidative Metabolism of Murine Macrophages
- Unit 14.6 Measurement of Bacterial Ingestion and Killing by Macrophages
- Unit 14.7 Assay for Macrophage‐Mediated Anti‐Tumor Cytotoxicity
- Unit 14.8 Measurement of Fcγ Receptor–Mediated Binding and Phagocytosis
- Unit 14.9 Measurement of Interferon‐Mediated Antiviral Activity of Macrophages
- Unit 14.10 Human Natural Killer Receptors, Co‐Receptors, and Their Ligands
- Unit 14.11 Isolation and Functional Use of Human NKT Cells
- Unit 14.12 Toll‐Like Receptors
- Unit 14.13 Characterization and Functional Analysis of Mouse Invariant Natural T (iNKT) Cells
- Unit 14.14 Measuring Autophagy in Macrophages
- Unit 14.15 Monocyte and Neutrophil Isolation and Migration Assays
- Unit 14.16 Measuring TLR Function in Transfectants
- Unit 14.17 Measurement of Myeloid Cell Immune Suppressive Activity
- Unit 14.18 Measurement of Tumor Cytolysis by Macrophages
- Unit 14.19 In Vivo and Ex Vivo Protocols for Measuring the Killing of Extracellular Pathogens by Macrophages
- Unit 14.20 Measurement of Macrophage Growth and Differentiation
- Unit 14.21 Measurement of Type I Interferon Production
- Unit 14.22 Quantitative Assessment of Macrophage Functions in Repair and Fibrosis
- Unit 14.23 Measuring the Killing of Intracellular Pathogens: Leishmania
- Unit 14.24 Measuring Matrix Metalloproteinase Activity in Macrophages and Polymorphonuclear Leukocytes
- Unit 14.25 Measurement of Macrophage‐Mediated Killing of Intracellular Bacteria, Including Francisella and Mycobacteria
- Unit 14.26 Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes
- Unit 14.27 Measuring Opsonic Phagocytosis via Fcγ Receptors and Complement Receptors on Macrophages
- Unit 14.28 Analysis of Gene Expression and Gene Silencing in Human Macrophages
- Unit 14.29 Target‐Induced Natural Killer Cell Loss as a Measure of NK Cell Responses
- Unit 14.30 Measurement of Phagocytosis, Phagosome Acidification, and Intracellular Killing of Staphylococcus aureus
- Unit 14.31 Measurement of Phagocytic Engulfment of Apoptotic Cells by Macrophages Using pHrodo Succinimidyl Ester
- Unit 14.32 Comparing Individual NK Cell Activity In Vitro
- Unit 14.33 Measuring Intravascular Migration of Mouse Ly6Clow Monocytes In Vivo Using Intravital Microscopy
-
Chapter 15 Animal Models for Autoimmune and Inflammatory Disease
- Introduction
- Unit 15.1 Experimental Autoimmune Encephalomyelitis in the Mouse
- Unit 15.2 Experimental Autoimmune Encephalomyelitis in the Rat
- Unit 15.3 The BB Rat as a Model of Human Insulin‐Dependent Diabetes Mellitus
- Unit 15.4 Adjuvant Arthritis in the Rat
- Unit 15.5 Collagen‐Induced Arthritis
- Unit 15.6 Experimental Autoimmune Uveoretinitis in the Rat and Mouse
- Unit 15.7 Experimental Autoimmune Thyroiditis in the Mouse
- Unit 15.8 Experimental Autoimmune Myasthenia Gravis in the Mouse
- Unit 15.9 The NOD Mouse: A Model for Insulin‐Dependent Diabetes Mellitus
- Unit 15.10 Streptococcal Cell Wall Arthritis
- Unit 15.11 Animal Models of IgA Nephropathy
- Unit 15.12 Induction of Autoimmune Disease by Depletion of Regulatory T Cells
- Unit 15.13 Induction of Inflammatory Bowel Disease in Immunodeficient Mice by Depletion of Regulatory T Cells
- Unit 15.14 Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy
- Unit 15.15 Mercuric Chloride–Induced Autoimmunity
- Unit 15.16 The Day‐3 Thymectomy Model for Induction of Multiple Organ‐Specific Autoimmune Diseases
- Unit 15.17 Autoimmune Ovarian Disease Induced by Immunization with Zona Pellucida (ZP3) Peptide
- Unit 15.18 Animal Models of Airway Sensitization
- Unit 15.19 Induction of TNBS Colitis in Mice
- Unit 15.20 Animal Models for SLE
- Unit 15.21 Creation of “Humanized” Mice to Study Human Immunity
- Unit 15.22 The K/BxN Arthritis Model
- Unit 15.23 Mouse Model for Pyelonephritis
- Unit 15.24 Mouse Models of Atherosclerosis
-
Chapter 16 Antigen Processing and Presentation
-
Chapter 17 Engineering Immune Molecules and Receptors
- Introduction
- Unit 17.1 Bacteriophage Library Construction and Selection of Recombinant Antibodies
- Unit 17.2 Monitoring Antigen‐Specific T Cells Using MHC‐Ig Dimers
- Unit 17.3 MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells
- Unit 17.4 In Situ Staining Using MHC Class I Tetramers
- Unit 17.5 Preparation of Stable Single‐Chain Trimers Engineered with Peptide, β2 Microglobulin, and MHC Heavy Chain
-
Chapter 18 Ligand‐Receptor Interactions in the Immune System
- Introduction
- Unit 18.1 Binding of Biotinylated Peptides to MHC Class II Proteins on Cell Surfaces
- Unit 18.2 Detection of Low‐Affinity Ligand‐Receptor Interactions at the Cell Surface with Fluorescent Microspheres
- Unit 18.3 Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture
- Unit 18.4 Measurement of Peptide‐MHC Interactions in Solution Using the Spin Column Filtration Assay
- Unit 18.5 Measurement of the Kinetics of Biomolecular Interactions Using the IAsys Resonant Mirror Biosensor
- Unit 18.6 Affinity‐Based Biosensors for Biomolecular Interaction Analysis
- Unit 18.7 Biotin Labeling and Quantitation of Cell‐Surface Proteins
- Unit 18.8 Measuring Protein‐Protein Interactions by Equilibrium Sedimentation
- Unit 18.9 Binding of Small Peptides to Immobilized Antibodies: Kinetic Analysis by Surface Plasmon Resonance
- Unit 18.10 Fluorescence Resonance Energy Transfer: Techniques for Measuring Molecular Conformation and Molecular Proximity
- Unit 18.11 Peptide Induction of Surface Expression of Class I MHC
- Unit 18.12 Competition‐Based Cellular Peptide Binding Assay for HLA Class I
- Unit 18.13 Supported Planar Bilayers for Study of the Immunological Synapse
- Unit 18.14 Measurement of Peptide Dissociation from MHC Class II Molecules
- Unit 18.15 Characterizing Protein‐Protein Interactions by Sedimentation Velocity Analytical Ultracentrifugation
- Unit 18.16 Generation of Peptide MHC Class I Monomers and Multimers Through Ligand Exchange
- Unit 18.17 The MHC Motif Viewer: A Visualization Tool for MHC Binding Motifs
- Unit 18.18 Analysis of the Targeting Properties of Fc Chimeric Proteins and Antibodies in Mice In Vivo
-
Chapter 19 Animal Models for Infectious Diseases
- Introduction
- Unit 19.1 Schistosomiasis
- Unit 19.2 Animal Models for the Analysis of Immune Responses to Leishmaniasis
- Unit 19.3 Animal Models for Toxoplasma gondii Infection
- Unit 19.4 Experimental Asexual Blood Stage Malaria Immunity
- Unit 19.5 Animal Models of Mycobacteria Infection
- Unit 19.6 Animal Models for Candidiasis
- Unit 19.7 A Mouse Model for Cytomegalovirus Infection
- Unit 19.8 Helicobacter Animal Models
- Unit 19.9 Animal Model for Infection with Listeria monocytogenes
- Unit 19.10 Animal Models Using Lymphocytic Choriomeningitis Virus
- Unit 19.11 Influenza Virus
- Unit 19.12 Animal Model of Nippostrongylus brasiliensis and Heligmosomoides polygyrus
- Unit 19.13 Cecal Ligation and Puncture
- Unit 19.14 Infection of Mice with Francisella as an Immunological Model
-
Chapter 20 Animal Models for Tumor Immunology
- Introduction
- Unit 20.1 B16 as a Mouse Model for Human Melanoma
- Unit 20.2 Mouse 4T1 Breast Tumor Model
- Unit 20.3 Mouse SaI Sarcoma Tumor Model
- Unit 20.4 The P815 Mastocytoma Tumor Model
- Unit 20.5 The TRAMP Mouse as a Model for Prostate Cancer
- Unit 20.6 Models for Lymphoma
- Unit 20.7 Identification of Human Tumor Antigens by Serological Analysis of Recombinant cDNA Expression Libraries (SEREX)
- Unit 20.8 Carcinoembryonic Antigen Transgenic Mouse Models for Immunotherapy and Development of Cancer Vaccines
- Unit 20.9 ErbB2 Transgenic Mice: A Tool for Investigation of the Immune Prevention and Treatment of Mammary Carcinomas
- Unit 20.10 Molecular Cloning and Characterization of MHC Class I– and II–Restricted Tumor Antigens Recognized by T Cells
- Unit 20.11 The Immune Response to Tumors
-
Chapter 21 Microscopy
-
Chapter 22 Isolation and Differentiation of Stem and Progenitor Cells
-
Section A Sources and Methods to Obtain Stem and Progenitor Cells
-
Section B Isolation of Murine Stem and Progenitor Cells
-
Section F Differentiation of Special Populations of Stem and Progenitor Cells
- Unit 22F.1 Isolation of Prolymphocytes from Bone Marrow and Fetal Liver
- Unit 22F.2 In Vitro Differentiation and Measurement of B Cell Progenitor Activity in Culture
- Unit 22F.3 Measurement of Natural Killer Cell Progenitor Activity in Culture
- Unit 22F.4 Differentiation of Peripheral Blood Monocytes into Dendritic Cells
- Unit 22F.5 Differentiation and Characterization of Myeloid Cells
- Unit 22F.6 Culture, Expansion, and Differentiation of Murine Megakaryocytes
- Unit 22F.7 Differentiation of Human Erythroid Cells in Culture
- Unit 22F.8 Differentiation and Characterization of T Cells
- Unit 22F.9 Differentiation of Multipotent Adult Progenitor Cells into Functional Endothelial and Smooth Muscle Cells
- Unit 22F.10 Differentiation of Mast Cells from Embryonic Stem Cells
- Unit 22F.11 Differentiation and Characterization of Dendritic Cells from Human Embryonic Stem Cells
-
-
Appendix 1 Abbreviations and Useful Data
- Appendix 1B Amino Acids
- Appendix 1C Commonly Used Mouse Strains
- Appendix 1D Commonly Used Detergents
- Appendix 1E Murine Models of Immunodeficiency and Autoimmune Disease
- Appendix 1F Mouse Endogenous Superantigens: Ms and Mls‐like Determinants Encoded by Mouse Retroviruses
- Appendix 1G HLA Type of EBV‐Transformed Human B Cell Lines
- Appendix 1H Commonly Used Rat Strains
- Appendix 1I Peptide Binding Motifs for MHC Class I and II Molecules
- Appendix 1K Human MHC Genes and Products
- Appendix 1L Mouse MHC Genes and Products
- Appendix 1M Listing, Location, Binding Motifs, and Expression of Nonclassical Class I and Related Genes and Molecules
- Appendix 1N Overview of Protein Folds in the Immune System
- Appendix 1O Nomenclature of the Human T Cell Receptor Genes
- Appendix 1P Nomenclature of the Human Immunoglobulin Genes
- Appendix 1Q Safe Use of Radioisotopes
- Appendix 1R Receptors Involved in the Regulation of Murine NK Cells
- Appendix 1S Nomenclature and Serology of HLA Class I and Class II Alleles
- Appendix 1T Heat‐Shock Proteins
- Appendix 1U Large‐Scale Cell Culture
- Appendix 1V Biosafety: Guidelines for Working with Pathogenic and Infectious Microorganisms
- Appendix 1W Using Bioinformatics Tools for the Sequence Analysis of Immunoglobulins and T Cell Receptors
- Appendix 1X Paired Receptor Systems of the Innate Immune System
-
Appendix 2 Commonly Used Reagents and Equipment
-
Appendix 3 Commonly Used Immunological Techniques
- Appendix 3A Monitoring Cell Growth
- Appendix 3B Trypan Blue Exclusion Test of Cell Viability
- Appendix 3C Wright‐Giemsa and Nonspecific Esterase Staining of Cells
- Appendix 3D Labeling Cells in Microtiter Plates for Determination of [3H]Thymidine Uptake
- Appendix 3E Diagnosis and Treatment of Mycoplasma‐Contaminated Cell Cultures
- Appendix 3F Obtaining Human Peripheral Blood Cells
- Appendix 3G Cryopreservation and Thawing of Cells
- Appendix 3H Dialysis and Concentration of Protein Solutions
- Appendix 3I Column Chromatography of Antibodies and Fragments
- Appendix 3J Detection and Quantitation of Radiolabeled Proteins and DNA in Gels and Blots
- Appendix 3K Silanizing Glassware
- Appendix 3L Quantitation of DNA and RNA with Absorption and Fluorescence Spectroscopy
- Appendix 3M Preparing Frozen Bacterial Stocks
- Appendix 3N Transformation of E. coli by Electroporation
- Appendix 3O Gram Staining
-
Appendix 4 The CD System of Leukocyte Surface Molecules
* Looking for a protocol from this title that does not appear here? You can find it on Wiley Online Library



